PNC Financial Services Group’s CureVac CVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-82
Closed -$1K 4533
2022
Q1
$1K Buy
82
+22
+37% +$439 ﹤0.01% 4329
2021
Q4
$2K Buy
60
+5
+9% +$201 ﹤0.01% 4137
2021
Q3
$3K Hold
55
﹤0.01% 4032
2021
Q2
$4K Buy
55
+45
+450% +$4.5K ﹤0.01% 3919
2021
Q1
$1K Hold
10
﹤0.01% 4017
2020
Q4
$1K Buy
+10
New +$766 ﹤0.01% 3888

Other funds holding CVAC

PNC Financial Services Group's CVAC Position: Q2 2022 in Review

PNC Financial Services Group sold out of CureVac (CVAC) in Q2 2022, closing a stake of 82 shares — an estimated $1K sold.

PNC Financial Services Group first reported a position in CVAC in Q4 2020 and held it in 6 quarters. The position peaked at $4K in Q2 2021. 88 funds tracked by Wall St. Rank hold CVAC as of Q2 2022.

  • PNC Financial Services Group reported no remaining CureVac position as of Q2 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 82 CureVac shares in Q2 2022, an estimated $1K.
  • PNC Financial Services Group first reported a position in CureVac in Q4 2020 and held it in 6 quarters.
  • PNC Financial Services Group's CureVac position peaked at $4K in Q2 2021.
  • 88 funds tracked by Wall St. Rank held CureVac as of Q2 2022.

Based on PNC Financial Services Group's 13F filing for Q2 2022, filed 12 Aug 2022.